TS EAMCET Counselling 2020: Seat allotment result declared tseamcet.nic.in; confirm admission by 17 Nov

-

TS EAMCET second round seat allotment result 2020 has been declared by the Telangana State Council of Higher Education (TSCHE). Candidates who registered for the Telangana State Engineering Agricultural and Medical Common Entrance Test (TS EAMCET) counselling 2020 can check the allotment list at tseamcet.nic.in.

Students who have been shortlisted in the round two seat allotment will have to confirm their admission online and pay the requisite fee by 17 November.

This is the final phase seat allotment result. This year TSCHE counselling was held in two phases.

Seats have been allotted to candidates on the basis of rank secured by them in the entrance examination, option entered during the online counselling application and availability of seats.

Steps to check TS EAMCET counselling 2020 round 2 seat allotment result:

Step 1: Go to TS EAMCET's official website - tseamcet.nic.in.

Step 2: On the homepage, tap on the link that mentions, TS EAMCET allotment result round 2.

Step 3: You will be directed to a new page where you will have to enter your TS EAMCET admit card number, password, and date of birth.

Step 4: The round 2 seat allotment result will open on your screen.

Step 5: Check for your name and college allotted to you before saving and taking a print.

As per a report by NDTV, candidates will have to verify their documents before the final admission. They will be required to provide their TS EAMCET 2020 rank card, admit card, passing certificates from Class 6 to 12.

Candidates will have to furnish their photo ID, caste certificate (if applicable), domicile certificate, residential certificate, transfer certificate from the school last attended.

TS EAMCET result 2020 was declared in October. This year 75 percent of students qualified the entrance test. A total of 1,19,183 students took the test, of which 89,739 qualified.

 



from Firstpost India Latest News https://ift.tt/2Up7MpK
FP Trending

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more